Primary reticulum cell sarcoma of bone. Significance of clinical features upon the prognosis

ENVELOPE: enfortumab vedotin in patients with advanced small bowel adenocarcinoma refractory or intolerant to platinum-based therapy-phase II investigator-initiated trial (NCCH2412/MK015).

ESMO gastrointestinal oncology·2026

Impact of travel costs on disparities in precision oncology clinical trials.

ESMO real world data and digital oncology·2026

An open-label phase Ib/II study of trastuzumab deruxtecan combined with nivolumab and CAPOX for HER2-low gastroesophageal adenocarcinoma.

ESMO gastrointestinal oncology·2026

Exploring novel therapeutic targets in small bowel adenocarcinoma: insights from claudin 18.2, nectin-4, and HER3 expression analysis.

ESMO open·2025

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with gastric cancer.

ESMO open·2024

Chemotherapy after nivolumab for advanced gastric cancer (REVIVE): a prospective observational study.

ESMO open·2023

Maintenance therapy with low dose cyclophosphamide does not increase the risk of second malignancies: The European Pediatric Soft Tissue Sarcoma Study Group RMS2005 study experience.

Cancer·2026

Population-level diagnostic and radiation treatment trends of low-risk prostate cancer.

Cancer·2026

Body mass index at diagnosis, postdiagnosis change, and role of metabolic comorbidities in relation to survival in nonmetastatic renal cell carcinoma patients.

Cancer·2026

Generative artificial intelligence in medical oncology: A clinically focused narrative review of large language, vision-language, and agentic artificial intelligence systems.

Cancer·2026

Risk factors and outcome of children and young adults with initially unresected nonrhabdomyosarcoma soft tissue sarcoma: An analysis from the International Soft Tissue Sarcoma Consortium.

Cancer·2026

Patterns of physical activity and health care costs in older individuals with a history of cancer.

Cancer·2026

Predicting recurrence risk after neoadjuvant therapy in breast cancer: a single-center retrospective cohort study integrating residual cancer burden and immune microenvironment features.

Frontiers in oncology·2026

Prognostic associations of PD-L1 expression and BAP1 loss in pleural mesothelioma: a retrospective single-center cohort from Colombia.

Frontiers in oncology·2026

Multiparametric MRI radiomics for preoperative prediction of tumor budding grade in rectal cancer.

Frontiers in oncology·2026

IVIM-based habitat imaging for non-invasive assessment of Ki-67 proliferation status in cervical cancer.

Frontiers in oncology·2026

Diagnostic performance of next-generation sequencing in thyroid nodules and molecular correlates of tumor aggressiveness in papillary thyroid carcinoma.

Frontiers in endocrinology·2026

Multimodal radiomics based on dynamic contrast-enhanced ultrasound for predicting cervical lymph node metastasis in papillary thyroid carcinoma with Hashimoto's thyroiditis.

Frontiers in oncology·2026

Primary reticulum cell sarcoma of bone. Significance of clinical features upon the prognosis

Related Experiment Videos

Related Concept Videos

ENVELOPE: enfortumab vedotin in patients with advanced small bowel adenocarcinoma refractory or intolerant to platinum-based therapy-phase II investigator-initiated trial (NCCH2412/MK015).

Impact of travel costs on disparities in precision oncology clinical trials.

An open-label phase Ib/II study of trastuzumab deruxtecan combined with nivolumab and CAPOX for HER2-low gastroesophageal adenocarcinoma.

Exploring novel therapeutic targets in small bowel adenocarcinoma: insights from claudin 18.2, nectin-4, and HER3 expression analysis.

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with gastric cancer.

Chemotherapy after nivolumab for advanced gastric cancer (REVIVE): a prospective observational study.

Maintenance therapy with low dose cyclophosphamide does not increase the risk of second malignancies: The European Pediatric Soft Tissue Sarcoma Study Group RMS2005 study experience.

Population-level diagnostic and radiation treatment trends of low-risk prostate cancer.

Body mass index at diagnosis, postdiagnosis change, and role of metabolic comorbidities in relation to survival in nonmetastatic renal cell carcinoma patients.

Generative artificial intelligence in medical oncology: A clinically focused narrative review of large language, vision-language, and agentic artificial intelligence systems.

Risk factors and outcome of children and young adults with initially unresected nonrhabdomyosarcoma soft tissue sarcoma: An analysis from the International Soft Tissue Sarcoma Consortium.

Patterns of physical activity and health care costs in older individuals with a history of cancer.

Predicting recurrence risk after neoadjuvant therapy in breast cancer: a single-center retrospective cohort study integrating residual cancer burden and immune microenvironment features.

Prognostic associations of PD-L1 expression and BAP1 loss in pleural mesothelioma: a retrospective single-center cohort from Colombia.

Multiparametric MRI radiomics for preoperative prediction of tumor budding grade in rectal cancer.

IVIM-based habitat imaging for non-invasive assessment of Ki-67 proliferation status in cervical cancer.

Diagnostic performance of next-generation sequencing in thyroid nodules and molecular correlates of tumor aggressiveness in papillary thyroid carcinoma.

Multimodal radiomics based on dynamic contrast-enhanced ultrasound for predicting cervical lymph node metastasis in papillary thyroid carcinoma with Hashimoto's thyroiditis.

Primary reticulum cell sarcoma of bone. Significance of clinical features upon the prognosis

Related Experiment Videos

Related Concept Videos

Related Articles